resveratrol has been researched along with atrial natriuretic factor in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X | 1 |
| Chih, CL; Hu, BR; Huang, SS; Lin, JF; Lin, SM; Nien, MW; Su, HH; Tsai, SK | 1 |
| Tan, Y; Yao, F; Zhang, N; Zhang, Q | 1 |
| Jin, L; Li, B; Lian, J; Lin, Y; Liu, J; Wang, J; Xiao, W; Zhang, X; Zhou, L; Zhu, J | 1 |
| Chen, GH; Hu, J; Li, JL; Wang, HN; Xu, T; Yao, HQ | 1 |
| El-Kadi, AOS; Shoieb, SM | 1 |
6 other study(ies) available for resveratrol and atrial natriuretic factor
| Article | Year |
|---|---|
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.
Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Collagen Type I; Echocardiography; Hemodynamics; Male; Mice; Myocardial Ischemia; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Ventricular Remodeling | 2008 |
Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cells, Cultured; Glucosides; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Superoxides; Ventricular Myosins | 2015 |
Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Cell Size; Cells, Cultured; Endoplasmic Reticulum Stress; Gene Expression; Heat-Shock Proteins; Isoproterenol; Microscopy, Electron, Transmission; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2016 |
Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Energy Metabolism; Female; Gene Silencing; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyruvate Kinase; Rats, Sprague-Dawley; Resveratrol; Sirtuins | 2020 |
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
Topics: Angiotensin II; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Myosin Heavy Chains; Protective Agents; Resveratrol; Vasoconstrictor Agents | 2020 |